-
Mashup Score: 0Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity - 2 year(s) ago
Key Points. We describe the clinical strategy implemented for successful treatment and outcome of pre-engraftment SARS-CoV2 infection in HCT recipient.Robust le
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity - 2 year(s) ago
Key Points. We describe the clinical strategy implemented for successful treatment and outcome of pre-engraftment SARS-CoV2 infection in HCT recipient.Robust le
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Key Points. Recurrent thrombosis can present in antiphospholipid syndrome despite anticoagulation, antiplatelet, and immunosuppressive therapies.Complement inhi
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion–associated myeloid neoplasm - 2 year(s) ago
Key Points. This is the first report of long-term survival of a patient with FIP1L1-RARA–associated neoplasm treated with intensive multiagent therapy.Integrati
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis - 2 year(s) ago
Key Points. BRAF-mutated blood cells contribute to the disease phenotype in LCH.Vemurafenib inhibits systemic inflammation and rapidly improves the clinical pic
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 9Daratumumab for immune thrombotic thrombocytopenic purpura - 2 year(s) ago
Key Points. Treatment of iTTP with daratumumab leads to disappearance of ADAMTS13 inhibitor and restoration of normal ADAMTS13 activity.Targeting of plasma cell
Source: American Society of HematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Key Points. Somatic UBA1 mutations define VEXAS in men with late-onset systemic inflammatory disease and cytopenia.Features summarizing VEXAS include cytopenia,
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Key Points. We report a bilineal process with truncal U2AF1 mutation and lineage-specific secondary mutations in B-lymphoblast and myeloid populations.This case
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6
Key Points. Red blood cell exchange should be considered in sickle cell trait with refractory stuttering priapism.
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Key Points. We report a case of VITT following Ad26.COV2.S COVID-19 vaccination without radiographically demonstrable thrombosis at presentation.Early VITT reco
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Robust levels of SARS-CoV-2-specific and functional T cells rapidly expanded early post-HCT and may have contributed to viral clearance. https://t.co/7YHoLyQb1u #exceptionalcasereport #immunobiologyandimmunotherapy #transplantation https://t.co/KMNkNaCplE